These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11230001)

  • 1. Pramipexole augmentation in panic with agoraphobia.
    Marazziti D; Presta S; Pfanner C; Dell'Osso L; Cassano GB
    Am J Psychiatry; 2001 Mar; 158(3):498-9. PubMed ID: 11230001
    [No Abstract]   [Full Text] [Related]  

  • 2. Pramipexole in refractory bipolar depression.
    Goldberg JF; Frye MA; Dunn RT
    Am J Psychiatry; 1999 May; 156(5):798. PubMed ID: 10327923
    [No Abstract]   [Full Text] [Related]  

  • 3. D-3 receptor agonists: combined action neurologic and neuropsychiatric agents.
    Cummings JL
    J Neurol Sci; 1999 Feb; 163(1):2-3. PubMed ID: 10223401
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibromyalgia and pramipexole: promise and precaution.
    Holman AJ
    J Rheumatol; 2003 Dec; 30(12):2733. PubMed ID: 14719231
    [No Abstract]   [Full Text] [Related]  

  • 5. Tiagabine improves panic and agoraphobia in panic disorder patients.
    Zwanzger P; Baghai TC; Schüle C; Minov C; Padberg F; Möller HJ; Rupprecht R
    J Clin Psychiatry; 2001 Aug; 62(8):656-7. PubMed ID: 11561942
    [No Abstract]   [Full Text] [Related]  

  • 6. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease.
    Bennett JP; Piercey MF
    J Neurol Sci; 1999 Feb; 163(1):25-31. PubMed ID: 10223406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.
    Sporn J; Ghaemi SN; Sambur MR; Rankin MA; Recht J; Sachs GS; Rosenbaum JF; Fava M
    Ann Clin Psychiatry; 2000 Sep; 12(3):137-40. PubMed ID: 10984002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole for depression.
    Ostow M
    Am J Psychiatry; 2002 Feb; 159(2):320-1. PubMed ID: 11823287
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of pramipexole in REM sleep behavior disorder.
    Fantini ML; Gagnon JF; Filipini D; Montplaisir J
    Neurology; 2003 Nov; 61(10):1418-20. PubMed ID: 14638967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of cocaine-induced panic.
    Louie AK; Lannon RA; Rutzick EA; Browne D; Lewis TB; Jones R
    Biol Psychiatry; 1996 Nov; 40(9):938-40. PubMed ID: 8896786
    [No Abstract]   [Full Text] [Related]  

  • 12. Pramipexole treatment for cocaine cravings.
    Rosenbaum JF; Fredman SJ
    Am J Psychiatry; 1999 Nov; 156(11):1834. PubMed ID: 10553755
    [No Abstract]   [Full Text] [Related]  

  • 13. Lamotrigine administration in panic disorder with agoraphobia.
    Masdrakis VG; Papadimitriou GN; Oulis P
    Clin Neuropharmacol; 2010 May; 33(3):126-8. PubMed ID: 20502131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pramipexole for the treatment of uremic restless legs in patients undergoing hemodialysis.
    Miranda M; Kagi M; Fabres L; Aguilera L; Alvo M; Elgueta L; Erazo S; Venegas P
    Neurology; 2004 Mar; 62(5):831-2. PubMed ID: 15007148
    [No Abstract]   [Full Text] [Related]  

  • 15. Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test.
    Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Meco G
    Funct Neurol; 2002; 17(4):199-201. PubMed ID: 12675263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
    Siuciak JA; Fujiwara RA
    Psychopharmacology (Berl); 2004 Sep; 175(2):163-9. PubMed ID: 14985923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ropinirole and pramipexole, the new agonists.
    Hobson DE; Pourcher E; Martin WR
    Can J Neurol Sci; 1999 Aug; 26 Suppl 2():S27-33. PubMed ID: 10451757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction: pramipexole: a novel dopamine agonist for the treatment of Parkinson's disease.
    de Yebenes JG
    Eur J Neurol; 2000 May; 7 Suppl 1():1-2. PubMed ID: 11054151
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of the reversible monoamine oxidase-A inhibitor brofaromine in social phobia complicated by panic disorder with or without agoraphobia.
    Bakish D
    J Clin Psychopharmacol; 1994 Feb; 14(1):74-5. PubMed ID: 8151007
    [No Abstract]   [Full Text] [Related]  

  • 20. Ondansetron in the treatment of panic disorder.
    Schneier FR; Garfinkel R; Kennedy B; Campeas R; Fallon B; Marshall R; O'Donnell L; Hogan T; Liebowitz MR
    Anxiety; 1996; 2(4):199-202. PubMed ID: 9160623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.